Background: D-Alanine:D-alanine Ligase is essential for bacterial cell
wall synthesis, assembling one of the subunits used for peptidoglycan
crosslinking. The resulting aminoacyl-D-Ala-D-Ala strand is the Achil
les' heel of vancomycin-susceptible bacteria, binding of vancomycin to
this sequence interferes with crosslinking and blocks cell-wall synth
esis. A mutant enzyme (VanA) from vancomycin-resistant Enterococcus fa
ecium has been found to incorporate oc-hydroxy acids at the terminal s
ite instead of D-Ala; the resulting depsipeptides do not bind vancomyc
in, yet function in the crosslinking reaction. To investigate the bind
ing specificity of these ligases, we examined their inhibition by a se
ries of substrate analogs. Results: Phosphinate and phosphonate dipept
ide analogs (which, after phosphorylation by the enzyme, mimic interme
diates in the ligation reaction) were prepared and evaluated as revers
ible inhibitors of the wild-type ligases DdlA and DdlB from Escherichi
a coli and of the mutant enzyme VanA. Ki values were calculated for th
e first stage of inhibitor binding according to a mechanism in which i
nhibitor competes with D-Ala for both substrate binding sites. DdlA is
potently inhibited by phosphinates but not by phosphonates, while Ddl
B and VanA show little discrimination; both series of compounds inhibi
t DdlB strongly and VanA weakly. Conclusions: VanA has greatly reduced
affinity for all the Ligands studied. The relative affinities of the
inhibitors in the reversible binding step are not, however, consistent
with the substrate specificities of the enzymes. We propose a mechani
sm in which proton transfer from the attacking nucleophile to the depa
rting phosphate occurs directly, without intervention of the enzyme.